Differences in affinity of monoclonal and naturally acquired polyclonal antibodies against Plasmodium falciparum merozoite antigens

Reddy, SB; Anders, RF; Cross, N; Mueller, I; Senn, N; Stanisic, DI; Siba, PM; Wahlgren, M; Kironde, F; Beeson, JG; Persson, KE

Author(s): Reddy, SB; Anders, RF; Cross, N; Mueller, I; Senn, N; Stanisic, DI; Siba, PM; Wahlgren, M; Kironde, F; Beeson, JG; Persson, KE;
Details: Publication Year 2015-07-03,Volume 15,Issue #1,Page 133
Journal Title: BMC Microbiology
Publication Type: Journal Article
Abstract: BACKGROUND: Malaria is a major global cause of deaths and a vaccine is urgently needed. RESULTS: We have employed the P. falciparum merozoite antigens MSP2-3D7/FC27 and AMA1, used them in ELISA, and coupled them in different ways using surface plasmon resonance (SPR) and estimated affinity (measured as kd) of monoclonal as well as naturally-acquired polyclonal antibodies in human plasma. There were major differences in kd depending on how the antigens were immobilized and where the His-tag was placed. For AMA1 we could see correlations with invasion inhibition. Using different immobilizations of proteins in SPR, we could see only moderate correlations with levels of antibodies in ELISA, indicating that in ELISA the proteins were not uniformly bound and that antibodies with many specificities exist in natural immunisation. The correlations between ELISA and SPR were enhanced when only parasite positive samples were included, which may indicate that high affinity antibodies are difficult to maintain over long periods of time. We found higher kd values for MSP2 (indicating lower affinity) compared to AMA1, which might be partly explained by MSP2 being an intrinsically disordered protein, while AMA1 is globular. CONCLUSIONS: For future vaccine studies and for understanding immunity, it is important to consider how to present proteins to the immune system to achieve highest antibody affinities.
Publisher: BioMed Central
Research Division(s): Population Health And Immunity
PubMed ID: 26149471
Publisher's Version: https://doi.org/10.1186/s12866-015-0461-1
Open Access at Publisher's Site: http://www.biomedcentral.com/1471-2180/15/133
NHMRC Grants: NHMRC/637406, NHMRC/637315,
Terms of Use/Rights Notice: Refer to copyright notice on published article.
Documents: Royal et al BMC Micorbiology.pdf - (0.70MB, application/pdf)

Creation Date: 2015-07-15 02:16:01

Last Modified: 2019-04-01 09:06:56